Study: Inker 2021, New England Journal of Medicine
New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race
Citation
Inker LA, Eneanya ND, Coresh J, Tighiouart H et al (2021). New England Journal of Medicine. PubMed id 34554658.
Cards that cite this study (1)
Each card gives its own wording for who was tested, how and what was found.
- Kidney disease, the APOL1 gene and the eGFR race adjustment Tier B moderate
B 8,254 participants (31.5% Black) for the creatinine equation and 5,352 (39.7% Black) for creatinine plus cystatin C; validated in 4,050 (14.3% Black) (n=4050 in validation)
Development and validation of eGFR equations against measured GFR.
The current equation with a race term overestimated measured GFR in Black participants by a median of 3.7 mL/min/1.73 m2 and slightly in others (0.5). Omitting the race term underestimated it in Black participants by 7.1. A new race-free creatinine equation underestimated in Black participants by 3.6 and overestimated in non-Black by 3.9. Creatinine plus cystatin C equations were more accurate with smaller differences between groups.
As recorded in this card: Inker LA, Eneanya ND, Coresh J, Tighiouart H et al (2021), New England Journal of Medicine, [primary]
Note: US data; funded by the National Institute of Diabetes and Digestive and Kidney Diseases.
This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.